Concepedia

Antonella Perotti

AP

13

Publications

555

Citations

11

H-Index

2001

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

European Institute of Oncology

Kantonsspital St. Gallen

Humanitas University

Sarah Cannon

Antonella Perotti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2001–2023

13

Publications

13

Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails

Cristiana Sessa, Filippo de Braud, Antonella Perotti et al. · Journal of Clinical Oncology · 2005 · 164 citations

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

Antonella Perotti, Cristiana Sessa, Andrea Mancuso et al. · Annals of Oncology · 2009 · 72 citations · Full text

, , +9

Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer

Cristiana Sessa, Antonella Perotti, Cristina Noberasco et al. · European Journal of Cancer · 2008 · 57 citations

, , +6

Phase IB Study of the mTOR Inhibitor Ridaforolimus With Capecitabine

Antonella Perotti, Alberta Locatelli, Cristiana Sessa et al. · Journal of Clinical Oncology · 2010 · 43 citations

Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule

Cristiana Sessa, Antonella Perotti, Anna Lladó et al. · Annals of Oncology · 2007 · 41 citations

, , +5

Rows per page

1–5 of 13